E51G (p.Glu51Gly) variant of NFKBIA (NF-kappa-B inhibitor alpha)

E51G (p.Glu51Gly) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.20 / 1. The record also includes population frequency data and structural context.

E51G (p.Glu51Gly) variant details